Presented by Jeffrey A. Zonder, MD - Professor from the Department of Oncology at the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine.
Question - what is the "typical longevity" of taking tafamidis, for example. The charts all seem to go down eventually, but it appeared that the tafamidis stabilized after a period of time.
Question - what is the "typical longevity" of taking tafamidis, for example. The charts all seem to go down eventually, but it appeared that the tafamidis stabilized after a period of time.
😳👵